AI Diagnostics: Microsoft Claims Superiority Over Physicians

For patients facing difficult medical diagnoses, the landscape of diagnostic support is shifting. A new study published in Science indicates that an artificial intelligence system developed by Microsoft can correctly identify complex medical conditions more than twice as often as generalist physicians working alone. This development suggests that AI tools may soon serve as a more reliable second opinion for cases that traditionally require specialist intervention, potentially altering how clinicians approach ambiguous symptoms.

The system, known as MAI-DxO, operates by coordinating multiple AI agents that mimic a panel of doctors. These agents question virtual patients, order tests, and debate potential diagnoses. In simulations using complex cases from the New England Journal of Medicine, the system achieved an 83% accuracy rate. In comparison, primary care doctors and general internists, who had access to reference materials, were correct only 36% of the time. It is important to note that these complex cases are typically handled by specialists or teams in real-world settings, a group not included in the comparative benchmark.

Dominic King, vice president of Health at Microsoft AI, described the findings as substantial. He highlighted the growing mismatch between medical expertise supply and demand as the primary challenge in healthcare delivery. By publishing these results, Microsoft joins peers like Google and OpenAI in claiming that AI can match or exceed human performance. However, the study’s data suggests that much of the improvement stems from more powerful underlying models, with Microsoft’s orchestration layer adding incremental gains.

Cost and efficiency were also measured. When using OpenAI’s GPT-5 model, the standalone system cost approximately $8,400 per case with 78.9% accuracy. The MAI-DxO system reduced this cost by about $3,000 but only improved accuracy by four points. With the newer GPT-5.5 model, accuracy jumped from 72% to nearly 87% with the assistance of the orchestration system, though costs remained similar. The benefits were less pronounced for emergency department cases, where both methods performed similarly.

Mustafa Suleyman, CEO of Microsoft AI, views this as a step toward 'medical superintelligence.' He revealed that the company is partnering with the Mayo Clinic to train a healthcare foundation model, with a release planned for next year. Suleyman predicts a 'coding style breakthrough' for medical records in 2027, allowing for highly accurate predictions of patient outcomes. He expects healthcare models to improve by an order of magnitude in capability within the next 24 to 36 months.

To validate these capabilities in real-world settings, Microsoft has established a partnership with Beth Israel Deaconess Medical Center in Boston. The study will evaluate clinical reasoning across various hospital environments. Patients will receive standard care, while those who consent will also interact with the AI system. Researchers will then compare the AI’s recommendations against those of human doctors. This approach mirrors recent efforts by Google, which published a study in The Lancet evaluating its own diagnostic AI in urgent care settings.

Microsoft is positioning this technology as part of a broader strategy to build medical superintelligence, defined as surpassing contemporary human-led health systems in reasoning and coordination. The company aims to move beyond simple benchmarking and integrate deeply with clinicians to improve outcomes. With existing tools for dictation and radiology, Microsoft sees this diagnostic system as a critical expansion of its healthcare portfolio, aiming to become the state-of-the-art provider of clinical decision support in the coming years.